Next-level medicine with ease.

Next-level medicine
with ease.

We are a clinical-stage biopharmaceutical company unlocking difficult-to-produce biologics based on a transformative manufacturing platform.


Developing unique medicines for patients.


Two innovative therapies for orphan diseases.


Smart biologics enabled by moss.


A unique opportunity in complement
disorders: Factor H (CPV-104)

Eleva’s team combines decades of scientific and industry experience. We relentlessly pursue those therapeutic opportunities, where our technology and expertise can make a key difference and deliver next-level medicines to patients.

  • Dr. Holger Niederkrüger
    Technical Alliance Manager
  • Dr. Andreas Busch
    Chief Operations Officer
  • Karin Heidenreich, M.Sc.
    Senior Director Clinical Program
  • Danielle Püschel
    Chief Financial Officer

Eleva will be at the forefront of unlocking unique biological therapies with an equally unique expression platform. Stay up to date on our progress to learn more about how Eleva can change patient’s lives and help forge therapies that might otherwise be neglected.

  • Jun 13, 2024

    ...will focus on diagnostics and the disease spectrum of C3 Glomerulopathy, zooming in on histological spectrum.

Stay in the loop and subscribe Eleva’s newsletter


Eleva offers a workplace that is focused on a valuable goal – bringing unique therapies to patients in need.

Next Page